首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >New Spisulosine Derivative promotes robust autophagic response to cancer cells
【24h】

New Spisulosine Derivative promotes robust autophagic response to cancer cells

机译:新的施霉素衍生物促进对癌细胞的稳健自噬反应

获取原文
获取原文并翻译 | 示例
           

摘要

Therapy resistance by evasion of apoptosis is one of the hallmarks of human cancer. Therefore, restoration of cell death by non-apoptotic mechanisms is critical to successfully overcome therapy resistance in cancer. By rational drug design approach, here we try to provide evidence that subtle changes in the chemical structure of spisulosine completely switched its cytotoxic function from apoptosis to autophagy. Our most potent molecule (26b) in a series of 16 synthesized derivatives showed robust autophagic cell death in diverse cancer cells sparing normal counterpart. Compound 26b mediated lethal autophagy induction was confirmed by formation of characteristic autophagic vacuoles, LC3 puncta formation, upregulation of signature autophagy markers like Beclin and Atg family proteins. Altogether, we have detected novel autophagy inducer small molecule which can be tested further for drug discovery research. (C) 2020 Elsevier Masson SAS. All rights reserved.
机译:抑制细胞凋亡的治疗耐药是人类癌症的标志之一。 因此,通过非凋亡机制恢复细胞死亡对于成功克服癌症治疗抗性至关重要。 通过合理的药物设计方法,我们尝试提供证据,即施霉素的化学结构的细微变化完全切换其从细胞凋亡到自噬的细胞毒性功能。 我们最有效的分子(26b)在一系列16个合成衍生物中显示出在不同癌细胞中施加正常对应的不同癌细胞中的鲁棒性动物死亡。 通过形成特征自噬液泡,LC3斑点形成,拟标志性自噬标志物的上调,介导致死的致命自噬诱导介导的致死自噬诱导,如BECLIN和ATG家族蛋白。 完全,我们检测到新型的自噬诱导剂小分子,可以进一步测试用于药物发现研究。 (c)2020 Elsevier Masson SAS。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号